Canlyniadau Chwilio - Frederik Marmé

Mireinio'r Canlyniadau
  1. 1
    Targeted Therapies in Triple-Negative Breast Cancer

    Targeted Therapies in Triple-Negative Breast Cancer gan Frederik Marmé, Andreas Schneeweiß

    Cyhoeddwyd 2015
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  2. 2
    Current and emerging treatment approaches for hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer

    Current and emerging treatment approaches for hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer gan Komal Jhaveri, Frederik Marmé

    Cyhoeddwyd 2023
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  3. 3
    Prognostic Cancer Gene Expression Signatures: Current Status and Challenges

    Prognostic Cancer Gene Expression Signatures: Current Status and Challenges gan Yuquan Qian, Jimmy Daza, Timo Itzel, Johannes Betge, Tianzuo Zhan, Frederik Marmé, Andreas Teufel

    Cyhoeddwyd 2021
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  4. 4
    Aesthetic and functional results after breast conserving surgery as correlates of quality of life measured by a German version of the Breast Cancer Treatment Outcome Scale (BCTOS)

    Aesthetic and functional results after breast conserving surgery as correlates of quality of life measured by a German version of the Breast Cancer Treatment Outcome Scale (BCTOS) gan Joerg Heil, Simone Holl, Michael Golatta, Geraldine Rauch, Joachim Rom, Frederik Marmé, Gerhard Gebauer, Christof Sohn

    Cyhoeddwyd 2010
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  5. 5
    The impact of human adipose tissue-derived stem cells on breast cancer cells: implications for cell-assisted lipotransfers in breast reconstruction

    The impact of human adipose tissue-derived stem cells on breast cancer cells: implications for cell-assisted lipotransfers in breast reconstruction gan Eva Koellensperger, Lilly-Claire Bonnert, Inka Zoernig, Frederik Marmé, Stefanie Sandmann, Günter Germann, Felix Gramley, Uwe Leimer

    Cyhoeddwyd 2017
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  6. 6
    Feasibility Study for Long-Term Cardiotoxicity in Dose-Dense Treated Cancer Patients

    Feasibility Study for Long-Term Cardiotoxicity in Dose-Dense Treated Cancer Patients gan Markus Heckmann, Julia Lehmann, Daniel Finke, F J Roll, Norbert Frey, Andreas Schneeweiss, Frederik Marmé, Lorenz Lehmann

    Cyhoeddwyd 2025
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  7. 7
    Humoral response to catumaxomab correlates with clinical outcome: Results of the pivotal phase II/III study in patients with malignant ascites

    Humoral response to catumaxomab correlates with clinical outcome: Results of the pivotal phase II/III study in patients with malignant ascites gan Marion Ott, Frederik Marmé, Gerhard Moldenhauer, Horst Lindhofer, Michael Hennig, R. Spannagl, Mirko M. Essing, R. Linke, Diane Seimetz

    Cyhoeddwyd 2011
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  8. 8
    Molecular and clinical dissection of CD24 antibody specificity by a comprehensive comparative analysis

    Molecular and clinical dissection of CD24 antibody specificity by a comprehensive comparative analysis gan Glen Kristiansen, Eda Machado, Niko P. Bretz, Christian Rupp, Klaus‐Jürgen Winzer, Anne-Kathleen König, Gerhard Moldenhauer, Frederik Marmé, Júlia Costa, Peter Altevogt

    Cyhoeddwyd 2010
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  9. 9
    Design and Development of <sup>99m</sup>Tc-Labeled FAPI Tracers for SPECT Imaging and <sup>188</sup>Re Therapy

    Design and Development of <sup>99m</sup>Tc-Labeled FAPI Tracers for SPECT Imaging and <sup>188</sup>Re Therapy gan Thomas Lindner, Annette Altmann, Susanne Krämer, Christian Kleist, Anastasia Loktev, Clemens Kratochwil, Frederik L. Giesel, Walter Mier, Frederik Marmé, Jürgen Debus, Uwe Haberkorn

    Cyhoeddwyd 2020
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  10. 10
    Health-related quality of life with sacituzumab govitecan in HR+/HER2− metastatic breast cancer in the phase III TROPiCS-02 trial

    Health-related quality of life with sacituzumab govitecan in HR+/HER2− metastatic breast cancer in the phase III TROPiCS-02 trial gan Hope S. Rugo, Peter Schmid, Sara M. Tolaney, Florence Dalenc, Frederik Marmé, Ling Shi, Wendy Verret, Anuj Shah, Mahdi Gharaibeh, Aditya Bardia, Javier Cortés

    Cyhoeddwyd 2024
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  11. 11
    Q-TWiST Analysis of Sacituzumab Govitecan vs. Chemotherapy in Previously Treated Patients with HR+/HER2− Metastatic Breast Cancer

    Q-TWiST Analysis of Sacituzumab Govitecan vs. Chemotherapy in Previously Treated Patients with HR+/HER2− Metastatic Breast Cancer gan Hope S. Rugo, Aditya Bardia, Peter Schmid, Sara M. Tolaney, Anandaroop Dasgupta, Ankita Kaushik, Wendy Verret, Marine Gosset, Adam Brufsky, Javier Cortés, Frederik Marmé

    Cyhoeddwyd 2025
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  12. 12
    Development of Fibroblast Activation Protein–Targeted Radiotracers with Improved Tumor Retention

    Development of Fibroblast Activation Protein–Targeted Radiotracers with Improved Tumor Retention gan Anastasia Loktev, Thomas Lindner, Eva-Maria Burger, Annette Altmann, Frederik L. Giesel, Clemens Kratochwil, Jürgen Debus, Frederik Marmé, Dirk Jäger, Walter Mier, Uwe Haberkorn

    Cyhoeddwyd 2019
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  13. 13
    Changes in chemotherapy usage and outcome of early breast cancer patients in the last decade

    Changes in chemotherapy usage and outcome of early breast cancer patients in the last decade gan André Hennigs, Fabian Riedel, Frederik Marmé, Hans‐Peter Sinn, Katja Lindel, Ádám Gondos, Katharina Smetanay, Michael Golatta, Christof Sohn, Florian Schuetz, Joerg Heil, Andreas Schneeweiß

    Cyhoeddwyd 2016
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  14. 14
    Body Fluid Exosomes Promote Secretion of Inflammatory Cytokines in Monocytic Cells via Toll-like Receptor Signaling

    Body Fluid Exosomes Promote Secretion of Inflammatory Cytokines in Monocytic Cells via Toll-like Receptor Signaling gan Niko P. Bretz, Johannes Ridinger, Anne-Kathleen Rupp, Katharina Rimbach, Sascha Keller, Christian Rupp, Frederik Marmé, Ludmila Umansky, Viktor Umansky, Tatjana Eigenbrod, Marei Sammar, Peter Altevogt

    Cyhoeddwyd 2013
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  15. 15
    Comparison of immunohistochemistry with PCR for assessment of ER, PR, and Ki-67 and prediction of pathological complete response in breast cancer

    Comparison of immunohistochemistry with PCR for assessment of ER, PR, and Ki-67 and prediction of pathological complete response in breast cancer gan Hans‐Peter Sinn, Andreas Schneeweiß, Marius Keller, Kornelia Schlombs, Mark Laible, Julia Seitz, Sotirios Lakis, Elke Veltrup, Peter Altevogt, Sebastian Eidt, Ralph M. Wirtz, Frederik Marmé

    Cyhoeddwyd 2017
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  16. 16
    TROPiCS-02: A Phase III Study Investigating Sacituzumab Govitecan in the Treatment of HR+/HER2- Metastatic Breast Cancer

    TROPiCS-02: A Phase III Study Investigating Sacituzumab Govitecan in the Treatment of HR+/HER2- Metastatic Breast Cancer gan Hope S. Rugo, Aditya Bardia, Sara M. Tolaney, Carlos L. Arteaga, Javier Cortés, Joohyuk Sohn, Frederik Marmé, Quan Hong, Rosemary Delaney, Amir Hafeez, Fabrice André, Peter Schmid

    Cyhoeddwyd 2020
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  17. 17
    Plasma MicroRNA Panel for Minimally Invasive Detection of Breast Cancer

    Plasma MicroRNA Panel for Minimally Invasive Detection of Breast Cancer gan Katarina Ćuk, Manuela Zucknick, Dharanija Madhavan, Sarah Schott, Michael Golatta, Jörg Heil, Frederik Marmé, Andrey Turchinovich, Hans‐Peter Sinn, Christof Sohn, H. Junkermann, Andreas Schneeweiß, Barbara Burwinkel

    Cyhoeddwyd 2013
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  18. 18
    Prognosis of breast cancer molecular subtypes in routine clinical care: A large prospective cohort study

    Prognosis of breast cancer molecular subtypes in routine clinical care: A large prospective cohort study gan André Hennigs, Fabian Riedel, Ádám Gondos, Hans‐Peter Sinn, Peter Schirmacher, Frederik Marmé, Dirk Jäger, Hans‐Ulrich Kauczor, Anne Stieber, Katja Lindel, Jürgen Debus, Michael Golatta, Florian Schütz, Christof Sohn, Jörg Heil, Andreas Schneeweiß

    Cyhoeddwyd 2016
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  19. 19
    Higher rate of severe toxicities in obese patients receiving dose-dense (dd) chemotherapy according to unadjusted body surface area: results of the prospectively randomized GAIN study

    Higher rate of severe toxicities in obese patients receiving dose-dense (dd) chemotherapy according to unadjusted body surface area: results of the prospectively randomized GAIN st... gan Jenny Furlanetto, W. Eiermann, Frederik Marmé, Toralf Reimer, Mattea Reinisch, Sabine Schmatloch, Elmar Stickeler, Christoph Thomssen, Michael Untch, Carsten Denkert, Gϋnter von Minckwitz, Bianca Lederer, Valentina Nekljudova, Karsten E. Weber, Sibylle Loibl, Volker Möbus

    Cyhoeddwyd 2016
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  20. 20
    Safety and efficacy of the therapeutic DNA-based vaccine VB10.16 in combination with atezolizumab in persistent, recurrent or metastatic HPV16-positive cervical cancer: a multicenter, single-arm phase 2a study

    Safety and efficacy of the therapeutic DNA-based vaccine VB10.16 in combination with atezolizumab in persistent, recurrent or metastatic HPV16-positive cervical cancer: a multicent... gan Peter Hillemanns, Michal Zikán, Frédéric Forget, Hannelore Denys, Jean‐François Baurain, Lukáš Rob, Linn Woelber, Paweł Blecharz, Mariusz Bidziński, Josef Chovanec, Frederik Marmé, Theresa Link, Christian Dannecker, Anders Rosholm, Kaja C. G. Berg, Roberto S Oliveri, Kristina Lindemann

    Cyhoeddwyd 2025
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:

Offerynnau Chwilio: